Not applicableStudy completedNCT02360267What this trial is testingPediatric Bipolar RegistryWho this might be right forBipolar DisorderDepressionMania+1 more The University of Texas Health Science Center, Houston 334
Large-scale testing (Phase 3)Study completedNCT01914393What this trial is testingPediatric Open-Label Extension StudyWho this might be right forSchizophreniaAutismBipolar Depression Sumitomo Pharma America, Inc. 702
Post-approval studies (Phase 4)Study completedNCT00391261What this trial is testingAn Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.Who this might be right forSchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more Cambridge Health Alliance 11
Post-approval studies (Phase 4)Ended earlyNCT00592683What this trial is testingOmega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and AdolescentsWho this might be right forPediatric Bipolar Disorder Massachusetts General Hospital 20
Post-approval studies (Phase 4)WithdrawnNCT01932541What this trial is testingOpen-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years OldWho this might be right forManiaBipolar IBipolar II+2 more Massachusetts General Hospital
Not applicableEnded earlyNCT01506232What this trial is testingBrain Activity Flow Patterns Analysis Using Evoked Response Potentials in Youth With ADHD, Bipolar Disorder, or Autism Spectrum Disorders: A Preliminary StudyWho this might be right forAttention Deficit Hyperactivity DisorderAutism Spectrum DisorderBipolar Disorder Massachusetts General Hospital 1
Large-scale testing (Phase 3)Study completedNCT04578756What this trial is testingOpen-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum DisorderWho this might be right forSchizophreniaBipolar I DisorderAutism Spectrum Disorder (ASD) AbbVie 310
Early research (Phase 1)Study completedNCT01620060What this trial is testingLurasidone Pediatric Pharmacokinetics StudyWho this might be right forSchizophreniaAutism Sumitomo Pharma America, Inc. 105
Large-scale testing (Phase 3)Enrolling By InvitationNCT04987229What this trial is testingLong-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsWho this might be right forBipolar I DisorderSchizophrenia Alkermes, Inc. 236
Post-approval studies (Phase 4)Study completedNCT01396486What this trial is testingInositol and Omega-3 Fatty Acids in Pediatric ManiaWho this might be right forPediatric Bipolar Spectrum Disorders Massachusetts General Hospital 69
Early research (Phase 1)Study completedNCT01206517What this trial is testingEvaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1)Who this might be right forSchizophreniaBipolar I Disorder Organon and Co 30
Large-scale testing (Phase 3)Looking for participantsNCT05303064What this trial is testingStudy to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderWho this might be right forSchizophreniaBipolar I Disorder Alkermes, Inc. 220
Not applicableUnknownNCT00592267What this trial is testingScreening Protocol for Children and Adolescents With Bipolar and Bipolar Spectrum DisorderWho this might be right forPediatric Bipolar Disorder Massachusetts General Hospital 1,000
Not applicableStudy completedNCT01804582What this trial is testingThe Family VOICE StudyWho this might be right forAutismAggressionBipolar Disorder+1 more University of Maryland, Baltimore 350
Post-approval studies (Phase 4)Study completedNCT01050582What this trial is testingEvaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in ChildrenWho this might be right forSchizophreniaBipolar DisorderAutistic Disorder+1 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 244
Early research (Phase 1)Looking for participantsNCT05025605What this trial is testingDetermining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar DisorderWho this might be right forSchizophreniaSchizo-Affective DisorderSchizophreniform; Schizophrenic+2 more BioXcel Therapeutics Inc 140
Large-scale testing (Phase 3)Study completedNCT00035802What this trial is testingEvaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I DisorderWho this might be right forBipolar DisorderAffective Disorders, PsychoticMood Disorders+1 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 13
Post-approval studies (Phase 4)Ended earlyNCT00592358What this trial is testingInvega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar DisorderWho this might be right forPediatric Bipolar Disorder Massachusetts General Hospital 17
Large-scale testing (Phase 3)Looking for participantsNCT06229210What this trial is testingSafety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum DisorderWho this might be right forSchizophreniaBipolar DisorderAutism Spectrum Disorder Intra-Cellular Therapies, Inc. 500